CELEX: 62019TA0550
Language: en
Date: 2020-06-25 00:00:00
Title: Case T-550/19: Judgment of the General Court of 25 June 2020 — Nitto Pharmaceutical Industries v EUIPO — Chiesi Farmaceutici (NOSTER) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark NOSTER — Earlier EU word mark FOSTER — Relative ground for refusal — Article 8(1)(b) of Regulation (EU) 2017/1001)

17.8.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 271/36
            
         
      Judgment of the General Court of 25 June 2020 — Nitto Pharmaceutical Industries v EUIPO — Chiesi Farmaceutici (NOSTER)
      (Case T-550/19) (1)
      
      (EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark NOSTER - Earlier EU word mark FOSTER - Relative ground for refusal - Article 8(1)(b) of Regulation (EU) 2017/1001)
      (2020/C 271/46)
      Language of the case: English
      
         Parties
      
      
         Applicant: Nitto Pharmaceutical Industries Ltd (Kyoto, Japan) (represented by: P. Voutilainen, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Chiesi Farmaceutici SpA (Parma, Italy) (represented by: C. de Callataÿ and T. de Haan, lawyers)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 May 2019 (Case R 2279/2018-5), relating to opposition proceedings between Chiesi Farmaceutici and Nitto Pharmaceutical Industries.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Nitto Pharmaceutical Industries Ltd to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Chiesi Farmaceutici SpA.
               
            
         (1)  OJ C 337, 7.10.2019.